drugset / Trial / NCT01324063
A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)
RandomizedTreatment
Summary
RATIONALE: Patient abstract not available PURPOSE: Patient abstract not available
Timeline
- Start
- 1986-11
- Primary completion
- 1994-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Daunorubicin | Small molecule | — | — |
| Subject | amsacrine | Small molecule | — | — |
| Subject | sargramostim | Protein / enzyme biologic | 5 ug/kg | Intravenous |